Inventor · disambiguated record
Boris Minev
Also filed as: MINEV BORIS · MINEV BORIS R
9 granted patents·19 pending applications·49 citations·filing 2005–2024
87Inventor score
Files withMYELOID THERAPEUTICS INC9BATU BIOLOGICS INC6CALIDI BIOTHERAPEUTICS INC5CALIDI BIOTHERAPEUTICS NEVADA INC2GENELUX CORP1
Top patents by PatentIndex Score
28 records- 0196US11918605B1Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·6 cites·30 claims
- 0296US11517589B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·9 cites·23 claims
- 0395US11918604B2Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Granted Mar 5, 2024·3 cites·25 claims
- 0493US10238700B2Oncolytic virus adjunct therapy with agents that increase virus infectivityGENELUX CORP·Filed 2014·Granted Mar 26, 2019·12 cites·25 claims
- 0593US10105436B2Smallpox vaccine for cancer treatmentCALIDI BIOTHERAPEUTICS INC·Filed 2016·Granted Oct 23, 2018·14 cites·28 claims
- 0688US10857225B2Smallpox vaccine for cancer treatmentCALIDI BIOTHERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·2 cites·29 claims
- 0787US2024207309A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0886US11607450B2Smallpox vaccine for cancer treatmentCALIDI BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·1 cites·21 claims
- 0985US11285194B2Combination immunotherapy approach for treatment of cancerCALIDI BIOTHERAPEUTICS INC·Filed 2015·Granted Mar 29, 2022·2 cites·16 claims
- 1080US2022175831A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1180US2022175830A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1280US2022202856A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1380US2024335530A1Smallpox vaccine for cancer treatmentCALIDI BIOTHERAPEUTICS NEVADA INC·Filed 2024·Application pending·0 cites
- 1479US2022118010A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1577US12036278B2Smallpox vaccine for cancer treatmentCALIDI BIOTHERAPEUTICS NEVADA INC·Filed 2023·Granted Jul 16, 2024·0 cites·19 claims
- 1676US2021252053A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerMYELOID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1767US2022241388A1Combination immunotherapy approach for treatment of cancerCALIDI BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1863US2017151281A1Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancerBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 1955US2008044484A1Use of polymeric nanoparticles for vaccine deliveryUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 2051US2016228547A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2150US2018008670A1Chimeric antigen receptor targeting of tumor endotheliumBATU BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2248US2008206270A1Enhancing Class I Antigen Presentation With Synthetic SequencesMINEV BORIS R·Filed 2005·Application pending·0 cites
- 2346US2014087362A1Methods for assessing effectiveness and monitoring oncolytic virus treatmentSZALAY ALADAR A·Filed 2013·Application pending·0 cites
- 2440US2018325948A1Tumor antigen modified dendritic cellsICHIM THOMAS·Filed 2016·Application pending·0 cites
- 2539US2018092951A1Virotherapy with an antibody combinationSTEMINNUNE INCORPORATED·Filed 2016·Application pending·0 cites
- 2639US2016237407A1Universal donor chimeric antigen receptor cellsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2738US2017021002A1Augmentation of cancer and cancer endothelial vaccine immunogenicity by histone deacetylase inhibitorsBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 2837US2016231323A1Protection of tcr signaling chains in cancer patients and enhancement of car-t cell therapyBATU BIOLOGICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Boris Minev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →